NCT02044822 · Interventional trial
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion
Overall registry status Terminated
Phase 2
Conditions B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion
Delaware Valley sites
- Hospital of the University of Pennsylvania, Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory